Salt and hypertension. Possibilities of the non-drug prevention of hypertension by dietary correction in an organized population of 25-to-49-year-old men and women for 3 years

封面

如何引用文章

全文:

详细

There is much evidence for a relation between sodium intake and blood pressure (BP). The aim of this study was to investigate the efficiency of a BP reduction when sodium was limited in men and women with high normal BP. Three-year dietary intervention significantly lowered systolic and diastolic BP (SBP and DBP) in the men and women from the intervention group (p<0,05) as compared to those in the control group that showed natural BP changes and a significant increase in BP during the 3-year period (p<0,05). Furthermore, there was a significant weight loss in the intervention group as compared to the control one. In the long-term follow-up, lower salt consumption significantly reduces SBP and DBP in the men and women with high normal BP as compared with the control group.

作者简介

O. Molchanova

State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow

Email: ovm-337@mail.ru
канд. мед. наук, вед. науч. сотр. лаб. применения амбулаторных диагностических методов в профилактике неинфекционных заболеваний ФГБУ ГНИЦ ПМ

A. Britov

State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow

Email: anbritov@yandex.ru
д-р. мед. наук, проф., вед. науч. сотр. отд. вторичной профилактики хронических неинфекционных заболеваний ФГБУ ГНИЦ ПМ

G. Andreeva

State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow

Email: galiya-61@mail.ru
канд. мед. наук, ст. науч. сотр. лаб. применения амбулаторных диагностических методов в профилактике неинфекционных заболеваний ФГБУ ГНИЦ ПМ

参考

  1. World Health Organization – Primary prevention of essential hypertension report of a WHO Scientific Group. Geneva, Switzerland: World Health Organization; Technical Report Series 1982; 678.
  2. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635–701.
  3. Guidelines for the management of arterial hypertension. Eur Heart J 2007; 28: 1462–536.
  4. Chobanian A.V., Bakris G.L., Black H.R. et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–52.
  5. Kempner W. Treatment of hypertensive vascular disease with rice diet. Am J Med 1948; 4: 545–77.
  6. Alderman M.H., Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Heath and Nutrition Examination Survey (NHANES I). Lancet 1998; 351: 781–5.
  7. He J, Klag M.J., Whelton P.K. et al. Migration,blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol 1991; 134: 1085–101.
  8. Forte J.G., Miguel J.M., Miguel M.J. et al. Salt and blood pressure: a community trial. J Hum Hypertens 1989; 3: 179–84.
  9. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297: 319–28.
  10. Brown I.J., Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol 2009; 38: 791–813.
  11. Graudal N.A., Hubeck-Graudal T, Jürgens G. Effects of low - sodium diet vs. highsodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012; 25: 1–15.
  12. Vasan R.S., Larson M.G., Leip E.P. et al. Assessment of frequency of progression to hypertension in non - hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682–6.
  13. Vasan R.S., Larson M.G., Leip E.P. et al. Impact of high - normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 45: 1291–7.
  14. Appel L.J., Moore T.J., Obarzanek E et al. A clinical trial of the effects ofdietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117–24.
  15. Elliott P, Stamler J, Nichols R et al. Intersalt revisited: further analyses of 24h sodium excretion and blood pressurewithin and across populations. Intersalt Cooperative Research Group. BMJ 1996; 312: 1249–53.
  16. Fitzsimons J.T. Angiotensin, thirst, and sodium appetite. Physiol Rev 1998; 78: 583–686.
  17. Dustan H.P., Tarazi R.C., Bravo E.L. Diuretic and diet treatment of hypertension. Arch Intern Med 1974; 133: 1007–11.
  18. Culter J.A., Follmann D, Elliott P and Suhl I. An overview ofrandomized trials of sodium reduction and blood pressure.Hypertension 1991; 17 Suppl. I, (1): 27–33.
  19. Gonzalez M.C., Cohen H.W., Sealey J.E. et al. Enduring direct association of baseline plasma renin activity with all - cause and cardiovascular mortality in hypertensive patients. Am J Hypertens 2011; 24: 1181–6.
  20. Furberg C.D. Public Health Policies: No Place for Surrogates. Am J Hypertens 2012; 25: 21.
  21. Sacks F.M., Svetkey L.P., Vollmer W.M. et al. Effects on blood pressure of reduced dietary sodium and the dietaryapproaches to stop hypertension (DASH) diet. N Engl J Med 2001; 344: 3–10.
  22. Cook N.R., Cutler J.A., Obarzanek E et al. for the Trials of Hypertension Prevention Collaborative Research Group. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow - up of the trials of hypertension prevention (TOHP) BMJ 2007; 334: 885.
  23. Blackburn H. Primary Prevention of High Blood Pressure. A Population Approach. Ann Clin Res 1983; 16 (Suppl. 43): 11–7.
  24. National Institute for Health and Clinical Excellence (NICE). Guidance on the prevention of cardiovascular disease at the population level; http://guidance.nice.org.uk/PH25 (Access verified 14 July 2010).

版权所有 © Eco-Vector, 2013

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。

##common.cookie##